Home Capital Results

Raffles Medical posts 14.1% drop in FY2019 earnings, but looks for novel measures to cope with Covid-19

Amala Balakrishner
Amala Balakrishner2/24/2020 12:24 PM GMT+08  • 3 min read
Raffles Medical posts 14.1% drop in FY2019 earnings, but looks for novel measures to cope with Covid-19
Raffles Medical is looking to remain profitable in 2020, barring unforeseen circumstances like the prolongation of the novel coronavirus outbreak
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Feb 24): Raffles Medical Group has posted a 14.1% drop in earnings to $58.1 million for FY2019 ended 31 December, from $67.7 million a year ago due to the start-up costs it incurred from the opening of Raffles Hospital Chongqing in January 2019.

This translates to earnings per share (EPS) of 3.32 cents for FY2019 on a fully diluted basis, compared to an EPS of 3.97 cents in FY2018.

This is in spite of a 6.7% increase in revenue to $522 million (from $489.1 million in FY2018), that comes from contributions in its healthcare and hospital services divisions. Income from its healthcare services was up 9% following an increase in corporate clients and a greater scope of services for insurance contracts. Meanwhile, its hospital services division grew 5.9% on higher patient load.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now